Merck to buy Verona Pharma for $10 billion
MLex Summary: Merck has agreed to buy Verona Pharma, a biotech firm specializing in respiratory diseases, for about $10 billion. The transaction is expected to close in the fourth quarter of...To view the full article, register now.
Already a subscriber? Click here to view full article